CYP2C8 and CYP2C9 mRNA expression profile in the human fetus

Frontiers in Genetics

Volumn 5, Issue MAR, 2014, Pages

  Johansson, Maria ^a   Strahm, Emmanuel ^a   Rane, Anders ^a   Ekström, Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cyp2c8; Cyp2c9; Drug metabolism; Fetus; Ibuprofen

Indexed keywords

CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; IBUPROFEN; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG HYDROXYLATION; ENZYME ACTIVITY; FEMALE; FETUS; FETUS LIVER; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; MASS SPECTROMETRY; MATERNAL AGE; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84897988886     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00058     Document Type: Article

References (23)

1. Blumenfeld, Y. J., Reynolds-May, M. F., Altman, R. B., and El-Sayed, Y. Y. (2010). Maternal-fetal and neonatal pharmacogenomics: a review of current literature. J. Perinatol. 30, 571-579. doi: 10.1038/jp.2009.183
2. Chang, S. Y., Li, W., Traeger, S. C., Wang, B., Cui, D., Zhang, H., et al. (2008). Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro. Drug Metab. Dispos. 36, 2513-2522. doi: 10.1124/dmd.108.022970
3. Glover, D. D., Amonkar, M., Rybeck, B. F., and Tracy, T. S. (2003). Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am. J. Obstet. Gynecol. 188, 1039-1045. doi: 10.1067/mob.2003.223
4. Goldstein, J. A. (2001). Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br. J. Clin. Pharmacol. 52, 349-355. doi: 10.1046/j.0306-5251.2001.01499.x
5. Goldstein, J. A., and de Morais, S. M. (1994). Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4, 285-299. doi: 10.1097/00008571-199412000-00001
6. Hakkola, J., Pasanen, M., Purkunen, R., Saarikoski, S., Pelkonen, O., Maenpaa, J., et al. (1994). Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem. Pharmacol. 48, 59-64. doi: 10.1016/0006-2952(94)90223-2
7. Hamman, M. A., Thompson, G. A., and Hall, S. D. (1997). Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochem. Pharmacol. 54, 33-41. doi: 10.1016/S0006-2952(97)00143-3
8. Hernandez, R. K., Werler, M. M., Romitti, P., Sun, L., and Anderka, M. (2012). Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am. J. Obstet. Gynecol. 206, 228.e1-228.e8. doi: 10.1016/j.ajog.2011.11.019
9. Hines, R. N. (2007). Ontogeny of human hepatic cytochromes P450. J. Biochem. Mol. Toxicol. 21, 169-175. doi: 10.1002/jbt.20179
10. Koukouritaki, S. B., Manro, J. R., Marsh, S. A., Stevens, J. C., Rettie, A. E., McCarver, D. G., et al. (2004). Developmental expression of human hepatic CYP2C9 and CYP2C19. J. Pharmacol. Exp. Ther. 308, 965-974. doi: 10.1124/jpet.103.060137
11. Lapple, F., von Richter, O., Fromm, M. F., Richter, T., Thon, K. P., Wisser, H., et al. (2003). Differential expression and function of CYP2C isoforms in human intestine and liver. Pharmacogenetics 13, 565-575. doi: 10.1097/00008571-200309000-00005
12. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. doi: 10.1006/meth.2001.1262
13. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
14. Marill, J., Cresteil, T., Lanotte, M., and Chabot, G. G. (2000). Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol. Pharmacol. 58, 1341-1348.
15. Naraharisetti, S. B., Lin, Y. S., Rieder, M. J., Marciante, K. D., Psaty, B. M., Thummel, K. E., et al. (2010). Human liver expression of CYP2C8: gender, age, and genotype effects. Drug Metab. Dispos. 38, 889-893. doi: 10.1124/dmd.109.031542
16. Ofori, B., Oraichi, D., Blais, L., Rey, E., and Berard, A. (2006). Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res. B Dev. Reprod. Toxicol. 77, 268-279. doi: 10.1002/bdrb.20085
17. Rodriguez-Antona, C., Donato, M. T., Pareja, E., Gomez-Lechon, M. J., and Castell, J. V. (2001). Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch. Biochem. Biophys. 393, 308-315. doi: 10.1006/abbi.2001.2499
18. Totah, R. A., and Rettie, A. E. (2005). Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance. Clin. Pharmacol. Ther. 77, 341-352. doi: 10.1016/j.clpt.2004.12.267
19. von Bahr, C., Groth, C. G., Jansson, H., Lundgren, G., Lind, M., and Glaumann, H. (1980). Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin. Pharmacol. Ther. 27, 711-725. doi: 10.1038/clpt.1980.102
20. Werler, M. M., Mitchell, A. A., Hernandez-Diaz, S., and Honein, M. A. (2005). Use of over-the-counter medications during pregnancy. Am. J. Obstet. Gynecol. 193(3 Pt 1), 771-777. doi: 10.1016/j.ajog.2005.02.100
21. Wortham, M., Czerwinski, M., He, L., Parkinson, A., and Wan, Y. J. (2007). Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab. Dispos. 35, 1700-1710. doi: 10.1124/dmd.107.016436
22. Yang, X., Zhang, B., Molony, C., Chudin, E., Hao, K., Zhu, J., et al. (2010). Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res. 20, 1020-1036. doi: 10.1101/gr.103341.109
23. Zeldin, D. C. (2001). Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276, 36059-36062. doi: 10.1074/jbc. R100030200